MAKING A DIFFERENCE IN THE LIFE OF OTHERS
LifeSci Consultancy
Life is defined by many delicate biological processes. From early life through adulthood and finally old age, our internal biological system determines how we function. Too often however, this internal system can become disturbed, leading to malfunction and diseases with sometimes detrimental outcomes.
Understanding the background of how the body functions and how to influence the internal processes, is key in the Life Sciences area. Through continuous development of new knowledge, researchers have been able to come with new interventions with proven health benefits. Key in this journey is not only the ability to identify such new innovations, but also to successfully bring these to market to serve patients around the world.
Is has been our lifelong passion to understand the biology of life and more importantly to drive creation, development, and marketing of products that can have a positive effect on the lives of people living with diseases. Not only professionally, but also personally, we experienced the effect of innovative pharmaceutical and nutritional products on life and wellbeing. Therefore, is has become our mission to “Make the difference in Life of Others” through dedicating our time and energy to help transform Science into Quality-of-Life improvements for patients.
We are here to help and guide companies in the Life Science arena to achieve their goals in developing and bringing such new innovations from lab bench to market. Through our over 20 years of combined experiences in the pharmaceutical and specialized nutritional industry, we can bring value to startup, scale up and end-to end-biotech/pharma/nutritional companies and help them to leave their legacy for mankind.
Knowledge of different stages of the full product life cycle
Personal experience with making the difference in lives of patients & their loved ones
Our team
Martine van Vugt, PhD
Owner & Managing Director of LifeSci Consultancy BV.
Martine holds over 20 years of biotechnology industry experience. She is a proven leader with successful track record of leading high-performing, global cross-functional teams in a networked biotech environment. Skilled in developing joint business value propositions, designing partnership structures and management of alliances. She is an expert in corporate transactional and licensing operations, including strategic partnering, in- and out-licensing as well as asset divestment and purchases. She is recognized internally and in industry for her strong leadership, communications, and negotiation skills. Furthermore, she effectively blends analytical skills with a natural leadership style grounded in integrity and science.
Martine has a background in Biology and Immunology. After graduating from the Agricultural University of Wageningen (NL) in 1994, she studied the role of FcR and received her PhD in Immunology from the University of Utrecht (NL) in 1998. She was granted a Dutch Cancer Foundation grant in 1998 and was co-promotor of several PhD students during 1998 and 2001. As a post-doctoral fellow, she studied dendritic cell vaccination therapy between 1998 and 2001.
In 2001 she joined the Danish biotechnology company Genmab as a scientist and moved to project management mid 2001. She managed numerous antibody discovery projects and has been responsible for senior management/alliance management of all product and technology partnerships. Since January 2010 she is heading the Project Management Department and implemented a standardized project management methodology based on PRINCE2. In addition, Martine has implemented program, portfolio, and alliance management processes at Genmab. Martine finished the Higher Management Program at the Business School Buren in the Netherlands in 2009.
In June 2011, Martine became Vice President Business Development and Project Management and was responsible with the business development team for the partnering strategy of Genmab. Since then, Martine has been leading business development activities for the majority of product- and technology partnerships.
As of January 1st, 2019, Martine became Genmab’s Chief of Staff and member of the Executive Committee, responsible for setting the company’s Strategic agenda.
She was also responsible for all Portfolio, Project and Alliance management and was active in Business Development & Operations (co-)leading corporate transactions and partnerships.
Since April 1st, 2022, she now heads up Corporate Strategy as well as Corparate & Business Development and Alliance management in the Executive team.
Martine is inventor on numerous patents and patent applications, including the block buster drugs DarzalexR for the treatment of Multiple Myeloma, which has been brought to market in partnership with Janssen, and the drug TEPEZZA for the treatment of Thyroid’s Eye Disease brought to patients by Horizon Pharma. Furthermore, she holds several national and international board positions, including HollandBio, Immagene and Noxxon. Martine is also an author on 20 international scientific publications.
Aldwin J.M. Vriesema, PhD
Owner & Managing Director of LifeSci Consultancy BV.
Aldwin holds over 22 years of research, development, and commercial experience in the medical, nutrition and devices industry. He is a highly engaged business driver, with an entrepreneurial, innovative, and pragmatic mindset, combining breakthrough strategic thinking with robust communicative, organizational, and stakeholder managerial skills. He is a proven people and team leader, with strong commercial and financial acumen. He has extensive experience with creating and developing commercially viable product & service propositions throughout the full value chain and product life cycle. He has demonstrated ability to establish value-adding partnerships for sustainable, profitable long-term growth.
Aldwin has a background in Biology and Medical Microbiology & Infectious Diseases. After graduating from the Agricultural University of Wageningen (NL) in 1994, he studied the role adaptive gene expression in oral bacteria involved in the heart disease Endocarditis at the Academic Medical Center in Amsterdam. He received his PhD in Medical Microbiology from the University of Amsterdam (NL) in 1999. Thereafter he joined the Wageningen Center for Food Sciences and was deployed at Department of Molecular Genetics and Gene Technology of the Dutch research institute TNO Nutrition where he studied the gene expression of bacterial wall components in lactic acid bacteria and potential role in oral vaccination strategies.
In 2000 he joined the R&D team of Dutch food company Numico, as a scientist in Biomedical Research, leading various projects in Nutrition, Gut Microbiota and Pre- & Probiotics. As of 2003, he subsequently became project leader for various key projects in Infant Nutrition, developing new nutritional modules with proven effectivity in infants with allergic food reactions. In 2006 he became Senior Project leader for the Medical Nutrition division, where his team developed a proven nutritional concept effective in reducing CD4+ T-cell decline in HIV / AIDS patients. In 2008, Aldwin joined the new Danone Research Centre for Specialized Nutrition as Director Research, where was part of the R&D management team. He led various teams involved in new product development, including the current blockbuster Compact range.
As per 2013, Aldwin became Medical Director of the Benelux country business unit of Nutricia Advanced Medical. In this role, he and his team were responsible for all Medical Affairs, as well as Regulatory and Markett Access matters related to full Benelux market.
In 2017 he became Sales Director for the Nutricia Advanced Medical Nutrition business unit in NL, where he led various teams related to all sales activities in the different medical channels including hospitals, pharmacies and wholesalers.
As per 2020, Aldwin was promoted to Director Healthcare Nutrition Solutions, driving sales of the full Infant Nutrition and Medical Nutrition & Devices in the different medical channels. In these various roles he was also part of the overarching Benelux management team.
Aldwin is inventor on over 20 patents and patent applications and has been an author on >40 international publications and abstracts. Aldwin has held several board positions, including the Dutch trade association VNFKD, the Belgium trade association UNAMEC and several other national associations of profit, governmental and non-profit parties.
How can we help you?
Are you looking for specific Life Science Consultancy expertise from experienced senior leaders for your company, or for some temporary interim management support to help kick start or grow your company?
